CG
MRNA icon

Colony Group’s Moderna MRNA Stock Holding History

Colony Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$2.36M Buy
22,889
+1,325
+6% +$148K 0.04% 310
2023
Q2 		$2.62M Buy
21,564
+3,174
+17% +$423K 0.04% 308
2023
Q1 		$2.82M Buy
18,390
+9,051
+97% +$1.49M 0.04% 296
2022
Q4 		$1.68M Buy
+9,339
New +$1.53M 0.02% 405
2022
Q2 		– Sell
-1,350
Closed -$233K – 848
2022
Q1 		$233K Sell
1,350
-625
-32% -$105K ﹤0.01% 776
2021
Q4 		$502K Buy
1,975
+750
+61% +$219K 0.01% 594
2021
Q3 		$471K Sell
1,225
-1,510
-55% -$557K 0.01% 582
2021
Q2 		$643K Buy
2,735
+307
+13% +$54.9K 0.01% 472
2021
Q1 		$318K Sell
2,428
-642
-21% -$93K 0.01% 630
2020
Q4 		$321K Buy
+3,070
New +$311K 0.01% 598

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Colony Group's MRNA Position: Q3 2023 in Review

Colony Group increased its Moderna (MRNA) stake by 6.1% in Q3 2023, buying an estimated $148K and bringing the position to 22,889 shares worth $2.36M. The position accounts for 0.04% of the portfolio, ranked #310.

Colony Group first reported a position in MRNA in Q4 2020 and has held it in 10 quarters since. The position peaked at $2.82M in Q1 2023. 890 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Colony Group held 22,889 shares of Moderna worth $2.36M as of Q3 2023.
  • Colony Group bought 1,325 Moderna shares in Q3 2023, an estimated $148K.
  • Moderna made up 0.04% of Colony Group's portfolio in Q3 2023, its #310 holding.
  • Colony Group first reported a position in Moderna in Q4 2020 and has held it in 10 quarters since.
  • Colony Group's Moderna position peaked at $2.82M in Q1 2023.
  • 890 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.